Sargent Bickham Lagudis LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 50 shares of XBI stock, worth $4,235. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$4,235% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding XBI
# of Institutions
847Shares Held
108MCall Options Held
17.7MPut Options Held
28.5M-
Goldman Sachs Group Inc New York, NY13.1MShares$1.11 Billion0.18% of portfolio
-
Morgan Stanley New York, NY10.9MShares$924 Million0.07% of portfolio
-
Citigroup Inc10.5MShares$887 Million0.45% of portfolio
-
Jpmorgan Chase & CO New York, NY10.4MShares$878 Million0.07% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A68.49MShares$719 Million1.54% of portfolio